Measuring patients' medical treatment preferences in advance care planning: development and validation of the Treat-Me-ACP instrument – a secondary analysis of a cluster-randomized controlled trial

Julia Jaschke,Rieke Schnakenberg,Katharina Silies,Almuth Berg,Änne Kirchner,Falk Hoffmann,Gabriele Meyer,Sascha Köpke,Juliane Köberlein-Neu
DOI: https://doi.org/10.1186/s12904-024-01404-8
2024-03-23
BMC Palliative Care
Abstract:Advance Care Planning interventions should be evaluated as broadly as possible to gain a holistic understanding of the Advance Care Planning process. However, validated early stage outcome instruments are lacking. Therefore, the Treatment-Preference-Measure-Advance Care Planning (Treat-Me-ACP) instrument was developed and validated as part of the cluster-randomized controlled trial STADPLAN (Study on Advance Care Planning in care-dependent community-dwelling older persons) to assess the effects of Advance Care Planning interventions on patients' medical treatment preferences.
health care sciences & services,health policy & services
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the lack of outcome tools in the early stage for evaluating patients' medical treatment preferences during the Advance Care Planning (ACP) process. Specifically, the researchers developed and validated a tool named "Treatment - Preference - Measure - Advance Care Planning (Treat - Me - ACP)", aiming to evaluate the effect of ACP interventions on patients' medical treatment preferences. This tool fills the gap in existing research where more attention has been paid to long - term ACP outcomes while lacking effective early - stage outcome measurement tools. **Background**: - ACP is a process that supports adults to understand and share their personal values, life goals and preferences for future medical care at any age or health condition. - Existing ACP research mainly focuses on long - term outcomes, such as the number of completed advance directives, the use of life - sustaining treatments, the number of hospitalizations and the length of hospital stay. - Currently, there are few tools for measuring early - stage ACP outcomes (such as changes in ACP awareness or dynamic changes in patients' preferences). **Objectives**: - Develop and validate the Treat - Me - ACP tool to evaluate the dynamic changes in patients' medical treatment preferences during the ACP process. - This tool is specifically designed to evaluate the changes in patients' preferences over time between the intervention group and the control group, as well as the responsiveness to preferences for life - sustaining treatments. Through this study, the authors hope to provide a reliable and valid tool to more in - depth explain the change process of individuals during the ACP process and provide an additional measurement means for evaluating the effectiveness of ACP interventions. This will not only help to better understand the immediate effects of ACP, but also provide important methodological support for future research.